The NDA government’s announcement of a health insurance scheme covering 500 million poor and needy…
Category: Healthcare
By Kiran Mazumdar Shaw The Finance Minister has presented a comprehensive and wide-ranging Budget for…
By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S.…
Financial Chronicle: Big Interview: Biocon CMD Kiran Mazumdar-Shaw spoke to FC on a range of…
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s…
A couple of years ago, India celebrated the success of its first Mars mission and…
The new fiscal year promises exciting opportunities for the Indian economy, which is scheduled to…
2016 was a landmark year for India as demonetisation nudged the country towards an inclusive,…
My Speech at The Chemical Heritage Foundation (CHF) I am deeply grateful to the Chemical…
By Kiran Mazumdar Shaw The hefty fine that Ranbaxy Laboratories will pay as part of…
